简
繁
EN
简
繁
EN
HOME
·
Telix Pharmaceuticals
Telix Pharmaceuticals: FDA Accepts Pixclara® NDA, PDUFA Goal Date Set for September 11, 2026
Tags:
Telix Pharmaceuticals
NDA
2026-04-10
Featured News
ETF
Improving Prospects Boost Sentiment,Fullgoal CSI Communication Equipment Theme ETF(159583) Rises 2.19% Intraday
ETF
GF China Security Environmental Protection Industry Index ETF(512580) Rises 2.99% Intraday,Policies Boost Demand in Segmented Sectors
ETF
Institutions: 2026 Sales Growth Promising,Hua Xia CSI New Energy Vehicles ETF(515030) Rises 3.88% Intraday
ETF
Hwabao WP CSI Electronic 50 ETF(515260) Rises 2.87% Intraday,Industrial Chain Demand Keeps Unleashing
ETF
Liquidity easing expectations persist alongside deep V-shaped rebound in US equities; Csop Mag Seven Etf (03454.HK) surges over 2% in afternoon trade
Research
NewTimeSpace | Breakthrough Designation for New Targeted Drug; GenFleet Therapeutics (02595.HK) Faces Commercialization Pressure Amid Heavy Book Losses
ETF
Market surges as ChiNext Index hits fresh 3-year high! CSOP SZSE CHINEXT ETF (03147.HK) jumps nearly 3.5%
ETF
China Universal CSI Chip Industry ETF(516920) Rises 2.08% as Computing Chip Industry Prosperity Continues to Climb
ETF
Guotai CSI Medical Service ETF(159828) Rises 1.44% in Morning Trading as Several Measures for Hierarchical Diagnosis and Treatment System Released
ETF
E Fund CNI Robot Industry ETF(159530) Rises 2.88% as 15th China Robotics Industry Conference Convenes
Scan QR Code
Download App